Price $3.40 |
Market Cap
132.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.89
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-22.2K
|
FCF
-0.7
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-72.80%
|
ROI
-
|
|
ROA
-47.60%
|
EPS Growth
16.40%
|
Current Ratio
4.8
|
Debt/Equity
25.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.41 | - | - | 68M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $2.10 | - | - | 8.8M | Strong Buy |
| Assembly Biosciences Inc (ASMB) | $24.87 | - | - | 369.6M | Strong Buy |
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
